54 Firmen mit Ergebnissen für "怎么查酒店开房信息- 查询微信10 1"

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

11467 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter ETH Entrepreneurship

1

... to aquatic organisms. 48 hr EC/LC50 Fathead minnow: 1- 10 mg/L, toxic 72 hr EC/LC50 Algae: 0.72 mg/L ... 48 hr EC/LC50 Fathead minnow: 1- 10 mg/L, toxic 72 hr EC/LC50 Algae: 0.72 mg/L, very toxic DATA FOR ... to aquatic organisms. 48 hr EC/LC50 Fathead minnow: 1- 10 mg/L, toxic 72 hr EC/LC50 Algae: 0.72 mg/L ... 48 hr EC/LC50 Fathead minnow: 1- 10 mg/L, toxic 72 hr EC/LC50 Algae: 0.72 mg/L, very toxic DATA FOR ... 1 ...

1

... 1 EG-Sicherheitsdatenblatt Verdichtetes Gasgemisch, leichter als Luft, erstickend wirkend ... . Erstellungsdatum : 28.01.2005 Version : 6.1 CH / D SDB Nr. : 1000 Überarbeitet am : 11.09.2012 Seite 1 / 2 1000 ... 1 ... 1 EG-Sicherheitsdatenblatt Verdichtetes Gasgemisch, leichter als Luft, erstickend wirkend ... 1 ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

20876 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter University of Zurich

1

... 1 Universitätsspital Zürich Klinik für ORL Direktor: Prof. Dr. R. Probst Bereich Forschung Leiter ... ....................................................................................................................... 2 1. GLOSSAR ... 1 ... 1 Universitätsspital Zürich Klinik für ORL Direktor: Prof. Dr. R. Probst Bereich Forschung Leiter ... 1 ...

1

... 1 Positionspapier der Arbeitsgruppe «Gender und Wissenschaftspolitik» Berücksichtigung der ... Forschungseinrichtungen Positionspapier der Arbeitsgruppe «Gender und Wissenschaftspolitik» 1 im Hinblick auf die ... 1 ... 1 Positionspapier der Arbeitsgruppe «Gender und Wissenschaftspolitik» Berücksichtigung der ... 1 ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

4120 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter Roche Glycart AG

cobas® HIV-1|ロシュ・ダイアグノスティックス

... 生化学者、学者およびその他の医学研究に関与している人 Your session has expired. Please log in again. cobas® HIV- 1   ・HIV- 1ゲノムの ... うち、薬剤耐性変異の起こりにくいgagとLTRの2つの領域をターゲットにしています。 ・変異型のHIV- 1も確実に検出できるため、見かけ上少ない値で報告される可能性を防ぎます。   Update ... り抜けてしまう可能性があります 1, 2 。 HIV- 1の定量測定は 頼できるデュアルターゲットアッセイで ロシュのデュアルターゲットアッセイは、感度、網羅性、安定性が向上した試薬を用いて効果的に ... HIV- 1を定量し、 頼性の高い結果をご提供します。 ・HIV- 1ゲノムのうち、薬剤耐性変異の起こりにくいgagとLTRの2つの領域をターゲットにしています。 ・変異型のHIV- 1も確実に検出できるため ... cobas® HIV- 1|ロシュ・ダイアグノスティックス ...

cobas® 4800 システム HSV 1 and 2 | ロシュ・ダイアグノスティックス

... ®4800 システム HSV 1 and 2は、性器病変でのHSV1型および2型の正確な同定を実現できるようデュアルターゲット法を採用しています。 最適化された感度および特異度による 頼性の高い同定 CEおよ ... AIDS. 22: 1- 10 3. Close   ... HSV 1 and 2 製品情報 関連製品 STIメニューをさらに充実   頼性のあるデュアルターゲット検出   ポリメラーゼ連鎖反応(PCR)法による遺伝子検査は、単純ヘルペスウイルス(HSV) 1型お ... デュアルターゲット法を採用しています。 最適化された感度および特異度による 頼性の高い同定   CEおよびFDA認可の核酸増幅検査(NAAT)に比べ、 cobas ®  4800 システム HSV 1 and 2は臨 ... cobas® 4800 システム HSV 1 and 2 | ロシュ・ダイアグノスティックス ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

4546 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter University Hospital Zurich​, Research and Education Office

Layout 1

... Layout 1 1 Kennt eure Arbeitsumgebung (inkl. Technik). 2 Kennt eure personellen und materiellen ... Ressourcen. Im Zweifelsfall: «Hilfe anfordern» 10 CRM-Prinzipien TASK MANAGEMENT (Aufgabenbewältigung ... Layout 1 ... Layout 1 1 Kennt eure Arbeitsumgebung (inkl. Technik). 2 Kennt eure personellen und materiellen ... Layout 1 ...

Layout 1

... Layout 1 Kursort UniversitätsSpital Zürich Institut für komplementäre und integrative Medizin ... der Welt, u.a. Deutschland, Nieder- lande, Schweiz, Malaysia, China, USA und Indonesien. 1 St d. 1 Std ... Layout 1 ... Layout 1 Kursort UniversitätsSpital Zürich Institut für komplementäre und integrative Medizin ... Layout 1 ...

Mehr Ergebnisse

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

28530 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter Somagenetix

Folie 1

... tro l (n =6 ) m as (n = 1 4) f a s ( n= 11 ) 0 5 10 15 20 *p<0.05; 2way ANOVA followed by Bonf ... -7M ERα-Agonist 10-7M ERβ-Agonist vehicle (mean= 1) 10-8M E2 Mean±SEM, n=4 carried out in triplicates ... tro l (n =6 ) m as (n = 1 4) f a s ( n= 11 ) 0 5 10 15 20 *p<0.05; 2way ANOVA followed by Bonf ... -7M ERα-Agonist 10-7M ERβ-Agonist vehicle (mean= 1) 10-8M E2 Mean±SEM, n=4 carried out in triplicates ... Folie 1 ...

Layout 1

... Layout 1 Mit Abstand Neue Chancen. 98’696.04 Franken Mikrokapseln. Gemeinsames Ziel Insekten App ... weltweit mehr als 10 Millionen Implantate eingesetzt werden. 10 Millionen Implantate? Ja. Ein grosser Teil ... Layout 1 ... Layout 1 Mit Abstand Neue Chancen. 98’696.04 Franken Mikrokapseln. Gemeinsames Ziel Insekten App ... Layout 1 ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

385 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter Blutspende SRK Zürich

Folie 1

... . 1: Schematic RHD/RHCE gene locus showing the 10 exons and common RH1 negative or very weak variants ... Folie 1 RHD DONOR SCREENING IN SWITZERLAND: RESOLVING NOVEL ALLELES BY NANOPORE-SEQUENCING S ... . 1: Schematic RHD/RHCE gene locus showing the 10 exons and common RH1 negative or very weak variants ... Folie 1 ... Folie 1 ...

Folie 1

... Folie 1 ADVERSE REACTIONS IN APHERESIS DONORS: A 10 YEAR RETROSPECTIVE ANALYSIS AT ZHBSD Maria ... and Table 1. The result of our retrospective 10-year analysis shows that apheresis procedures at ZHBSD ... Folie 1 ADVERSE REACTIONS IN APHERESIS DONORS: A 10 YEAR RETROSPECTIVE ANALYSIS AT ZHBSD Maria ... and Table 1. The result of our retrospective 10-year analysis shows that apheresis procedures at ZHBSD ... Folie 1 ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

323 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter InSphero AG

Slide 1

... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 1 1 0 1 0 0 1 0 0 0 0 5 0 1 0 0 1 5 0 2 0 0 S ita x s e n ta n (µ M ) C e ll v ia b il it y ... 0 = M4 32 .8 IC 5 0 = M1 90 .9 IC 5 0 = M3 48 . 1 H u m a n H e p /H u m a n N P C 1 1 0 1 0 0 1 0 ... Slide 1 ...

Folie 1

... Folie 1 Institutsname / Partner Logo Institute of Radiation Biology Identification of compounds ... 1. 3D-microtissue analysis platforms - changes in 3D-microtissue growth followed by high content ... Folie 1 Institutsname / Partner Logo Institute of Radiation Biology Identification of compounds ... 1. 3D-microtissue analysis platforms - changes in 3D-microtissue growth followed by high content ... Folie 1 ...

Mehr Ergebnisse

Standortförderung Kanton Zürich

https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html  

8090 Zürich, Walchestrasse 19

 +41 43 259 49 92
 standort@vd.zh.ch

The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.

Standortförderung Kanton Zürich

Walchestrasse 19

8090 Zürich

7527 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter Standortförderung Kanton Zürich

Layout 1

... bereits bestehenden Bauten ergaben, sind im Kanton Zürich 39 210 Hektaren Boden der NEK 1 bis 5 und 10 270 ... Layout 1 Gutes Ackerland sichern – notfalls kompensieren Fruchtfolgeflächen im Kanton Zürich sind ... bereits bestehenden Bauten ergaben, sind im Kanton Zürich 39 210 Hektaren Boden der NEK 1 bis 5 und 10 270 ... Layout 1 ... Layout 1 ...

Funktionsbereich 1

... Funktionsbereich 1 10/28 Klasse 20 Sehr grosse Sachverantwortung. Komplexer und schwieriger Aufgabenbereich mit ... Funktionsbereich 1 Kanton Zürich Finanzdirektion Personalamt Stand: 1. Januar 2018 1/28 Entwurf 19 ... Funktionsbereich 1 10/28 Klasse 20 Sehr grosse Sachverantwortung. Komplexer und schwieriger Aufgabenbereich mit ... Funktionsbereich 1 ... Funktionsbereich 1 ...

Mehr Ergebnisse

Bio-Technopark Schlieren-Zürich

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

Bio-Technopark Schlieren-Zürich

Wagistrasse 23

8952 Schlieren

208 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter Bio-Technopark Schlieren-Zürich

1. Digital Health Lab Day › BIO-TECHNOPARK® Schlieren-Zürich

... 1. Digital Health Lab Day Event date: 03.10.2019 1. Digital Health Lab Day – Life in numbers 5 on ... 1. Digital Health Lab Day › BIO-TECHNOPARK® Schlieren-Zürich ... https://www.bio-technopark.ch/en/events-en/external-events/ 1-digital-health-lab-day/ ... 1. Digital Health Lab Day › BIO-TECHNOPARK® Schlieren-Zürich ...

Molecular Partners Announces First Patient Dosed in Phase 1 Trial o...

... News Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ... announced that the first patient has been enrolled and dosed in a Phase 1 first-in-human study of MP0310 as ... Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ... - 1-trial-of-mp0310-a-novel-tumor-localized-immunotherapy/ ... Molecular Partners Announces First Patient Dosed in Phase 1 Trial of MP0310, a Novel Tumor ...

Mehr Ergebnisse

Neurimmune Therapeutics AG

http://www.neurimmune.com  

8952 Schlieren, Wagistrasse 18

 +41 44 755 46 46
 info@neurimmune.com

Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.

Neurimmune Therapeutics AG

Wagistrasse 18

8952 Schlieren

74 Ergebnisse für "怎么查酒店开房信息- 查询微信10 1" unter Neurimmune Therapeutics AG

Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's...

... February 19, 2017 BIIB076 Moves into Phase 1 for Alzheimer's Disease BIIB076 has moved into phase 1 ... NovaGo Therapeutics raises CHF 10 million to develop regenerative anti-Nogo therapy for stroke March 1 ... Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's Disease ... Neurimmune - 19.02.2017: BIIB076 Moves into Phase 1 for Alzheimer's Disease ...

Neurimmune - 07.03.2013: Biogen presents the first clinical data fr...

... Neurimmune March 7, 2013 Biogen presents the first clinical data from an ongoing Phase 1 study of ... clinical data from an ongoing Phase 1 trial, as well as new data on a direct comparison of mouse versions ... Neurimmune - 07.03.2013: Biogen presents the first clinical data from an ongoing Phase 1 study of ... -ongoing-phase- 1-study-of-biib037-in-mild-to-moderate-alzheimers.html ... Neurimmune - 07.03.2013: Biogen presents the first clinical data from an ongoing Phase 1 study of ...

Mehr Ergebnisse

Mehr Firmen

Nach oben